Funding
ProTip SAS, a specialist in the development of medical prostheses and implants made from porous titanium, has completed a first round funding of €1 million. The money has come from new investors, including business angels and entrepreneurs, and brings to €2 million the amount the Strasbourg-based company has raised since its formation in 2004.
The funding will enable ProTip to finish the development of an artificial larynx and start a clinical trial. There is a significant clinical need for an artificial larynx as there is no prosthesis available today.
“We believe this financing will take us to the completion of the design of this breakthrough prosthesis,” said Maurice Bérenger, CEO of ProTip. “The artificial larynx will be the first major milestone in the development of ProTip, [and] we have several other projects in an advanced development stage that will also address widespread unmet clinical needs.”
ProTip designs and manufactures prostheses and implants using porous titanium. The company says its expertise in manufacturing complex form factors based on medical-grade titanium microspheres means it can produce an infinite number of variants in final form, porosity and even composition, and no mould is required. The biomaterial can be implanted permanently.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
